Spondylitis

Common Name(s)

Spondylitis

Description for this condition is not yet available.
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Spondylitis" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
Top

How do you compare to others with this condition?

Privately answer questions about your health. Let resources, you select, come to you.

Anonymously share and see how your answers compare with others with this condition while privately providing key pieces of information to medical researchers, disease advocacy groups, and others ONLY YOU select to help speed up cures and better alternatives.

 
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Spondylitis" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
 
 
Top

Scientific Literature

Articles from the PubMed Database

Research articles describe the outcome of a single study. They are the published results of original research.
The terms "Spondylitis" returned 1468 free, full-text research articles on human participants. First 3 results:

Correlations of CYP2C9*3/CYP2D6*10/CYP3A5*3 gene polymorphisms with efficacy of etanercept treatment for patients with ankylosing spondylitis: A case-control study.
 

Author(s): Yuan-Yuan Chen

Journal: Medicine (Baltimore). 2017 Mar;96(9):e5993.

 

The tumor necrosis factor alpha (TNF-α) inhibitor etanercept has been proven to be effective in the treatment of ankylosing spondylitis (AS), while genetic polymorphism may affect drug metabolism or drug receptor, resulting in interindividual variability in drug disposition and efficacy. ...

Last Updated: 1 Mar 2017

Go To URL
Rituximab Can Induce Remission in a Patient with Ankylosing Spondylitis Who Failed Anti-TNF-α Agent.
 

Author(s): Fahmi AlDhaheri, Talal Almteri, Naji Dwid, Ahd Majdali, Nahed Janoudi, Hani Almoallim

Journal:

 

BACKGROUND Ankylosing spondylitis (AS) is a chronic inflammatory disease that predominantly affects the axial skeleton. The ability of anti-TNF-α agents to reduce disease activity in patients with axial spondyloarthritis (axSpA), including AS, has been demonstrated in multiple randomized ...

Last Updated: 9 Feb 2017

Go To URL
Does the position of conus medullaris change with increased thoracolumbar kyphosis in ankylosing spondylitis patients?
 

Author(s): Zhe Qu, Bang-Ping Qian, Yong Qiu, Yun-Peng Zhang, Jun Hu, Ze-Zhang Zhu

Journal: Medicine (Baltimore). 2017 Feb;96(6):e5963.

 

To date, only a few reports described the potential factors influencing the position of conus medullaris. One previous study revealed no significant change of conus locations in patients with idiopathic scoliosis; however, the effect of ankylosing spondylitis (AS)-related thoracolumbar ...

Last Updated: 8 Feb 2017

Go To URL

Reviews from the PubMed Database

Review articles summarize what is currently known about a disease. They discuss research previously published by others.
The terms "Spondylitis" returned 111 free, full-text review articles on human participants. First 3 results:

Progression rate of ankylosing spondylitis in patients with undifferentiated spondyloarthritis: A systematic review and meta-analysis.
 

Author(s): Qing Xia, Dazhi Fan, Xiao Yang, Xiaona Li, Xu Zhang, Mengmeng Wang, Shengqian Xu, Faming Pan

Journal: Medicine (Baltimore). 2017 Jan;96(4):e5960.

 

The idea that undifferentiated spondyloarthritis (uSpA) represents the early undifferentiated stage of ankylosing spondylitis (AS) and other well-defined SpA subtypes is well known. The gist of this study is to assess the rate estimate of patients with uSpA evolved to AS during long-term follow-up.

Last Updated: 25 Jan 2017

Go To URL
Do Anti-TNF Blockers Increase the Risk of Lung Involvement in Patients with Ankylosing Spondylitis or Psoriatic Arthritis? A Systematic Review.
 

Author(s): Fabiola Atzeni, Elisabetta Grillo, Ignazio F Masala, Piercarlo Sarzi-Puttini, Gareth T Jones

Journal: Isr. Med. Assoc. J.. ;18(3-4):154-5.

 

Lung involvement is a well-recognized extra-articular manifestation of ankylosing spondylitis (AS). Anecdotal reports suggest that the use of anti-TNF drugs may be related to lung disease and pulmonary fibrosis. To examine the association between anti-TNF drugs and the development ...

Last Updated: 27 May 2016

Go To URL
The Role of MicroRNAS in Ankylosing Spondylitis.
 

Author(s): Zheng Li, Sunny H Wong, Jianxiong Shen, Matthew T V Chan, William Ka Kei Wu

Journal: Medicine (Baltimore). 2016 Apr;95(14):e3325.

 

Ankylosing spondylitis (AS) is a common and genetically heterozygous inflammatory rheumatic disease characterized by new bone formation, ankylosis and inflammation of hip, sacroiliac joints and spine. Until now, there is no method for early diagnosis of AS and the effective treatment ...

Last Updated: 9 Apr 2016

Go To URL
 
 
Top

Symptoms, Diagnosis, and Treatment

There are currently no related results available in GeneReviews.

There are currently no related results available in Genetic Testing Registry.

 
 
Top

Clinical Trial Information This information is provided by ClinicalTrials.gov

Study of Efficacy and Safety of Secukinumab in Japanese Patients With Active Ankylosing Spondylitis
 

Status: Recruiting

Condition Summary: Ankylosing Spondylitis

 

Last Updated: 20 Apr 2016

Go to URL
Application of DCE-MRI in the Diagnosis of Brucellar Spondylitis
 

Status: Recruiting

Condition Summary: Brucella Spondylitis

 

Last Updated: 18 Jun 2016

Go to URL
Physical Training Program in Ankylosing Spondylitis
 

Status: Recruiting

Condition Summary: Ankylosing Spondylitis

 

Last Updated: 21 Feb 2017

Go to URL